Free Trial

64,804 Shares in Integral Ad Science Holding Corp. $IAS Purchased by Delphi Management Inc. MA

Integral Ad Science logo with Business Services background

Key Points

  • Delphi Management Inc. has invested $539,000 in Integral Ad Science Holding Corp., acquiring 64,804 shares in the second quarter, reflecting growing institutional interest in the company.
  • Integral Ad Science recently reported earnings of $0.07 per share for the last quarter, exceeding expectations and showing a revenue of $149.20 million against a consensus estimate of $143.02 million.
  • Analysts have shown optimism for the stock, with several upgrades and a consensus price target of $13.55, suggesting potential for future growth.
  • Five stocks to consider instead of Integral Ad Science.

Delphi Management Inc. MA bought a new position in shares of Integral Ad Science Holding Corp. (NASDAQ:IAS - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 64,804 shares of the company's stock, valued at approximately $539,000.

A number of other hedge funds have also made changes to their positions in IAS. DekaBank Deutsche Girozentrale acquired a new position in shares of Integral Ad Science during the 1st quarter valued at about $42,000. State of Wyoming acquired a new position in Integral Ad Science during the fourth quarter valued at approximately $51,000. Virtu Financial LLC acquired a new position in Integral Ad Science in the 1st quarter valued at $87,000. AlphaQuest LLC acquired a new position in Integral Ad Science in the 1st quarter valued at $93,000. Finally, Teacher Retirement System of Texas acquired a new position in Integral Ad Science in the 1st quarter valued at $96,000. Institutional investors and hedge funds own 95.78% of the company's stock.

Analyst Ratings Changes

Several brokerages have recently issued reports on IAS. Wall Street Zen raised Integral Ad Science from a "hold" rating to a "buy" rating in a research report on Sunday, August 10th. Stifel Nicolaus raised their target price on Integral Ad Science from $13.00 to $14.00 and gave the company a "buy" rating in a report on Tuesday, July 22nd. Barclays raised their target price on Integral Ad Science from $9.00 to $10.00 and gave the company an "equal weight" rating in a report on Friday, August 8th. Finally, Raymond James Financial lowered their price objective on shares of Integral Ad Science from $13.00 to $11.00 and set an "outperform" rating on the stock in a research note on Friday, August 8th. Six analysts have rated the stock with a Buy rating and six have given a Hold rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $13.55.

View Our Latest Stock Analysis on IAS

Insider Buying and Selling at Integral Ad Science

In other news, CEO Lisa Utzschneider sold 9,922 shares of the firm's stock in a transaction on Wednesday, August 6th. The stock was sold at an average price of $8.12, for a total value of $80,566.64. Following the completion of the sale, the chief executive officer directly owned 380,557 shares in the company, valued at approximately $3,090,122.84. This trade represents a 2.54% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Insiders sold 35,073 shares of company stock valued at $289,641 in the last three months. Company insiders own 2.00% of the company's stock.

Integral Ad Science Trading Down 0.5%

Shares of Integral Ad Science stock traded down $0.05 during mid-day trading on Friday, reaching $8.60. 382,995 shares of the stock were exchanged, compared to its average volume of 1,012,215. The company has a market cap of $1.43 billion, a price-to-earnings ratio of 25.28, a price-to-earnings-growth ratio of 1.20 and a beta of 1.57. The firm has a 50-day simple moving average of $8.57 and a 200 day simple moving average of $8.21. Integral Ad Science Holding Corp. has a fifty-two week low of $6.26 and a fifty-two week high of $13.62.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The company reported $0.07 earnings per share for the quarter, topping the consensus estimate of $0.04 by $0.03. The company had revenue of $149.20 million during the quarter, compared to analyst estimates of $143.02 million. Integral Ad Science had a net margin of 9.79% and a return on equity of 5.00%. Integral Ad Science has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. On average, research analysts predict that Integral Ad Science Holding Corp. will post 0.26 EPS for the current fiscal year.

Integral Ad Science Profile

(Free Report)

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.

Featured Stories

Institutional Ownership by Quarter for Integral Ad Science (NASDAQ:IAS)

Should You Invest $1,000 in Integral Ad Science Right Now?

Before you consider Integral Ad Science, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integral Ad Science wasn't on the list.

While Integral Ad Science currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.